Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
3.
Mayo Clin Proc ; 76(6): 664-6, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11393509

ABSTRACT

The high rate of dermatologic adverse effects associated with bupropion use may extend to its sustained-release preparation, currently prescribed extensively for smoking cessation as well as for treatment of depressive conditions. We report what we believe to be the first case, in a 31-year-old woman, of erythema multiforme after administration of sustained-release bupropion (Wellbutrin SR) for treatment of depression. This report emphasizes that prescribers must aggressively follow up their patients who have rashes or urticaria, discontinuing the medication as soon as erythema multiforme is suspected and watching closely for the emergence of potentially life-threatening dermatologic conditions.


Subject(s)
Antidepressive Agents, Second-Generation/adverse effects , Bupropion/adverse effects , Depressive Disorder/drug therapy , Erythema Multiforme/chemically induced , Administration, Oral , Adult , Aftercare , Anti-Inflammatory Agents/therapeutic use , Delayed-Action Preparations , Disease Progression , Drug Monitoring , Erythema Multiforme/classification , Erythema Multiforme/diagnosis , Erythema Multiforme/drug therapy , Female , Humans , Prednisone/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...